From biomedical engineering theory to clinical practice

As biomedical engineers, we are often engaged, explicitly or implicitly, in the search for better markers of risk for the diseases or treatments that motivate our research.  A recent scientific statement from the AHA, "Criteria for Evaluation of Novel Markers of Cardiovascular Risk", serves as an informative and important reminder that our efforts are usually just the tip of the iceberg.